SPONSOR
Instituto de Investigación Biomédica de Salamanca
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Coronary Artery DiseaseAtherosclerosisMyocardial IschemiaPersistent COVID ConditionDiffuse Large B Cell Lymphoma
Instituto de Investigación Biomédica de Salamanca is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Coronary Artery Disease, Atherosclerosis, Myocardial Ischemia, Persistent COVID Condition.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Instituto de Investigación Biomédica de Salamanca
How many clinical trials has Instituto de Investigación Biomédica de Salamanca sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Instituto de Investigación Biomédica de Salamanca, of which 3 are actively recruiting participants. These trials cover conditions including Coronary Artery Disease, Atherosclerosis, Myocardial Ischemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Instituto de Investigación Biomédica de Salamanca research focus on?
Instituto de Investigación Biomédica de Salamanca clinical trials span Coronary Artery Disease, Atherosclerosis, Myocardial Ischemia, Persistent COVID Condition, Diffuse Large B Cell Lymphoma. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Instituto de Investigación Biomédica de Salamanca clinical trial?
To participate in a Instituto de Investigación Biomédica de Salamanca trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Instituto de Investigación Biomédica de Salamanca trials with current recruitment status updated daily.
Clinical Trials by Instituto de Investigación Biomédica de Salamanca
NCT06977295
Recruiting
Evaluation of a Diagnostic Software for Coronary Artery Disease Using Retrospective CCTA Data (CODEX-1 Study)
Coronary Artery Disease
NCT07295483
Recruiting
Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)
Persistent COVID Condition
NCT06439173
Recruiting
Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow Microenvironment
Diffuse Large B Cell Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology